Methicillin-resistant Staphylococcus epidermidis (MRSE) endocarditis treated with linezolid

Paola Mancino; Claudio Ucciferri; Katia Falasca; Eligio Pizzigallo; Jacopo Vecchiet

doi:10.1080/00365540701509915

Methicillin-resistant Staphylococcus epidermidis (MRSE) endocarditis treated with linezolid

Scand J Infect Dis. 2008;40(1):67-73. doi: 10.1080/00365540701509915. Epub 2007 Jul 27.

Authors

Paola Mancino¹, Claudio Ucciferri, Katia Falasca, Eligio Pizzigallo, Jacopo Vecchiet

Affiliation

¹ Clinic of Infectious Diseases, Centre of Excellence on Ageing, University 'G. d'Annunzio' School of Medicine, Chieti-Pescara, Italy.

PMID: 17852941
DOI: 10.1080/00365540701509915

Abstract

Linezolid is not yet recognized as a standard therapy for infective endocarditis but its use becomes a necessity when infection is due to multidrug-resistant microorganisms. This report describes 1 patient with endocarditis treated with linezolid and 45 similar cases from the medical literature.

Publication types

Case Reports
Review

MeSH terms

Acetamides / therapeutic use*
Aged
Anti-Bacterial Agents / therapeutic use*
Endocarditis, Bacterial / drug therapy*
Humans
Linezolid
Male
Methicillin Resistance / drug effects*
Oxazolidinones / therapeutic use*
Prosthesis-Related Infections / drug therapy
Staphylococcal Infections / drug therapy*
Staphylococcus epidermidis / drug effects*
Staphylococcus epidermidis / pathogenicity

Substances

Acetamides
Anti-Bacterial Agents
Oxazolidinones
Linezolid